EUVIMEDEUVIMED entdecken
Multizentrische Studie

Association Between Elevation of Serum Alanine Aminotransferase and HBsAg Seroclearance After Nucleos(t)ide Analog Withdrawal

Ying-Nan Tsai iD, Jia-Ling Wu, Cheng-Hao Tseng iD, Shang-Chen Tseng, Chih-Lung Hung, Mindie H Nguyen iD, Jaw-Town Lin, Yao-Chun Hsu

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.18515 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Ying-Nan Tsai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Alanine Transaminase, Hepatitis B Surface Antigens, Hepatitis B, Chronic, Antiviral Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Science and Technology Council, E-Da Hospital, Tomorrow Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alanine aminotransferase (ALT) frequently elevates in chronic hepatitis B patients stopping nucleos(t)ide analogs (NAs).

Aims

To clarify the association between ALT elevation and HBsAg seroclearance after NA withdrawal.

Methods

This multicenter cohort study reviewed consecutive patients discontinuing NA between 2004/04/01 and 2022/05/24. Treatment initiation and discontinuation generally followed the Asian‐Pacific guidelines. Eligible patients had negative HBeAg and undetectable HBV DNA before treatment cessation, without malignancy, organ transplant or autoimmune disorders. We used competing risk analysis to estimate HBsAg seroclearance incidence and a time‐dependent model to investigate post‐cessation ALT elevation.

Results

Among 841 patients (74.7% male; median age, 53.2 years; median treatment duration, 34.7 months), 38 patients cleared HBsAg over a median follow‐up of 3.7 years, with a 10‐year cumulative incidence of 12.4%. The median peak ALT level was significantly lower in patients achieving HBsAg seroclearance versus not (93 vs. 127 U/L; p < 0.001). Hepatitis flare after NA cessation (> 5 times upper limit) was inversely associated with HBsAg seroclearance in the univariable analysis (sub‐distribution hazard ratio [SHR], 0.31; 95% confidence interval [CI], 0.13–0.73; p = 0.007), and the association was not significant (adjusted SHR, 0.42; 95% CI, 0.09–2.01; p = 0.28) in the multivariable analysis adjusted for pretreatment HBV DNA. Consistent results were observed in the sensitivity analyses with different ALT cutoffs and subgroup analysis adjusted for HBsAg levels at treatment cessation.

Conclusion

ALT elevation after NA cessation is not associated with HBsAg seroclearance following NA withdrawal, suggesting cytolytic pathways are not essential for a functional cure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alanine TransaminaseHepatitis B Surface AntigensHepatitis B, ChronicAntiviral AgentsNucleosidesHumansMaleMiddle AgedFemaleAdultCohort StudiesRetrospective StudiesAgedWithholding TreatmentDNA, Viral

Stichwörter der Autor:innen

HBsAg seroclearanceacute hepatitis flaresantiviral therapyfinite treatmenthepatitis B virus

Substanzen

Alanine TransaminaseHepatitis B Surface AntigensAntiviral AgentsNucleosidesDNA, Viral

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
  • School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
  • Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
  • Administrative Center, E-Da Healthcare System, Kaohsiung, Taiwan.
  • Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.

ORCID-Profile: Ying-Nan Tsai, Cheng-Hao Tseng, Mindie H Nguyen

Förderung

  • National Science and Technology Council
  • E-Da Hospital
  • Tomorrow Medical Foundation
  • E-Da Cancer Hospital

Zitieren

APA

Tsai, Y. N., Wu, J. L., Tseng, C. H., Tseng, S. C., Hung, C. L., Nguyen, M. H., Lin, J. T., & Hsu, Y. C. (2025). Association Between Elevation of Serum Alanine Aminotransferase and HBsAg Seroclearance After Nucleos(t)ide Analog Withdrawal. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18515

Vancouver

Tsai YN, Wu JL, Tseng CH, Tseng SC, Hung CL, Nguyen MH, et al. Association Between Elevation of Serum Alanine Aminotransferase and HBsAg Seroclearance After Nucleos(t)ide Analog Withdrawal. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18515

BibTeX
@article{Tsai2025,
  author = {Tsai, Ying-Nan and Wu, Jia-Ling and Tseng, Cheng-Hao and Tseng, Shang-Chen and Hung, Chih-Lung and Nguyen, Mindie H and Lin, Jaw-Town and Hsu, Yao-Chun},
  title = {Association Between Elevation of Serum Alanine Aminotransferase and HBsAg Seroclearance After Nucleos(t)ide Analog Withdrawal},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.18515}
}
Kostenlos starten →